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The c-Myc gene is a central regulator 
of proliferation, differentiation, cell sur-
vival, and neoplastic transformation.
Widespread interest in Myc stems from
the fact that it is a powerful oncogene
and is found mutated or overexpressed
in up to 30% of human cancers
(reviewed in Levens, 2003). Myc func-
tions in a transcription factor network
that includes the Mad and Max proteins
and acts upon E boxes containing genes.
The Myc network regulates a bewilder-
ingly large number of genes, approach-
ing 10% of human genes (Levens, 2003).
Given the strength of Myc’s onco-
genic activity, it is critical that its activity
be tightly controlled. Multiple mecha-
nisms ensure proper control in normal
cells, including regulated Myc turnover,
which occurs through the ubiquitin-pro-
teasome pathway (Salghetti et al., 1999).
Indeed, Myc is among the most unstable
proteins, with a half-life of ?30 min. Two
major mechanisms are responsible for
derailing normal Myc regulation: (1)
mutations in the structural gene that
block its rapid turnover and (2) trans-
locations that cause deregulated high-
level expression. However, the
molecules that maintain appropriate Myc
levels have not been identified. Now two
papers (Kim et al., 2003; von der Lehr et
al., 2003) in the May issue of Molecular
Cell have identified one component of
the machinery used to control Myc levels
through the ubiquitin pathway, the onco-
protein Skp2. Surprisingly, this ubiquitin
ligase is also required for induction of
Myc-responsive genes, suggesting that
ubiquitination not only promotes Myc
turnover but “licenses” its transcriptional
activity.
To explore the mechanism of Myc
turnover, Kim et al. used an elegant
yeast genetic system to ask whether 
Myc turnover occurred via an SCF
(Skp1/Cul1/F-box Protein) pathway.
When expressed in budding yeast, Myc
is quite unstable, with a half-life similar to
that seen in mammalian cells. Using tem-
perature-sensitive mutations in SCF
components, Kim et al. found that Myc
was stabilized under conditions where
the mutant SCF subunit was nonfunc-
tional, implicating the SCF pathway in
Myc turnover in yeast. F-box proteins
serve as substrate-specific receptors for
SCF complexes. By looking at Myc sta-
bility in cells lacking functional F-box pro-
teins (Grr1, Cdc4, and Met30), Kim et al.
found that removal of a single F-box pro-
tein—Grr1—caused Myc stabilization.
Given that Grr1 is a leucine-rich repeat
F-box protein (an Fbl), Kim et al. sur-
veyed a subset of the 18 known mam-
malian Fbl proteins for those that could
induce Myc turnover in Grr1-deficient
yeast. Of the genes examined, only one,
Skp2/Fbl1, supported Myc destruction.
In an independent study, von der
Lehr et al. asked whether Myc can asso-
ciate with a core component of the SCF
ubiquitin ligase, Cul1, and found that it
did. By testing three well-characterized
F-box proteins, von der Lehr et al. also
identified Skp2/Fbl1 as being capable of
binding Myc in tissue culture cells.
Through a series of domain mapping
experiments, both groups demonstrated
that Skp2 interacts with Myc via two dis-
tinct domains, the N-terminal Myc box II
(MbII) domain and the C-terminal
bHLHZip domain. If Skp2 is responsible
for Myc turnover in vivo, one would
expect that loss of Skp2 would lead to
Myc stabilization. Both groups demon-
strated that this is the case using domi-
nant-negative versions of Skp2 as well
as Skp2 siRNA. Taken together, these
data are consistent with Skp2 being a
component of the Myc turnover machin-
ery, but this is not the end of the story.
Skp2 is, perhaps, the best under-
stood mammalian F-box protein. SCFSkp2
is responsible for ubiquitination of the
Cdk inhibitor p27 in response to p27
phosphorylation (reviewed in Bashir and
Pagano, 2003). Moreover, Skp2 is over-
expressed in various tumors and, like
Myc, can collaborate with Ras to trans-
form cells. Thus, the finding that a
growth-promoting factor is responsible
for ubiquitin-dependent destruction of
another growth-promoting protein is
somewhat counterintuitive.
Previous work from the Tansey labo-
ratory had suggested a possible expla-
nation for this apparently unusual
relationship: that ubiquitination of certain
transcription factors is required to acti-
vate their ability to induce transcription.
This idea is based on the fact that many
transcriptional activators are unstable,
ubiquitinated proteins, and that instability
is frequently linked with one or more
transcriptional activation domains
(TADs) (Salghetti et al., 2000, 2001). For
example, in yeast, LexA-VP16 protein
fusions cannot activate reporter gene
expression under conditions where
VP16—the TAD—is not subject to ubiq-
uitination by the SCFMet30 ubiquitin ligase
(Salghetti et al., 2001). However, artificial
attachment of a single ubiquitin to LexA-
VP16 allows transcriptional activation in
the absence of SCFMet30 function. This
suggested the possibility that ubiquitina-
tion of TADs such as VP16 activates or
licenses their transcriptional activity
while simultaneously setting up their
destruction (Salghetti et al., 2001;
Tansey, 2001).
The finding that Skp2 associates
with TADs in Myc led Kim et al. and von
der Lehr et al. to test whether Skp2 is
involved in licensing Myc’s transcription-
al activity. Several lines of evidence are
consistent with this possibility. First,
using a Gal4-MbII fusion protein, Kim et
al. showed that overexpression of Skp2
stimulates both the ability of the Gal4-
MbII protein to be ubiquitinated and to
activate reporter constructs, while Skp2
knockdown by RNAi reduced the activity
of Gal4-MbII. Thus, Skp2 appears to be
important for induction of Myc target
genes by MbII. Second, Skp2 expression
has the unexpected property of being
able to induce the expression of several
endogenous Myc-dependent genes in
quiescent Rat1 cells, and the extent of
activation was similar to that seen with
Myc induction. Critically, Skp2 was
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unable to activate Myc-responsive gene
expression in c-Myc−/− Rat1 cells.
Moreover, and perhaps most surprising-
ly, Skp2 was unable to drive c-Myc−/−
cells into S phase from quiescence,
despite being able to destroy p27. Thus,
Myc is required for Skp2-driven S phase
entry in this setting.
Also consistent with the direct
involvement of Skp2 in Myc-dependent
transcription, von der Lehr et al. detected
Skp2 and Cul1 on the Myc-responsive
cyclin D2 promoter using chromatin
immunoprecipitation in wild-type but not
in c-Myc−/− cells. This suggests that
SCFSkp2 is brought to the cyclin D2 pro-
moter through an interaction with Myc.
Several subunits of the 19S regulatory
particle of the proteasome, as well as α2
subunit of the 20S proteasome core,
were also found associated with the
cyclin D2 promoter. Although AAA
ATPase subunits of the 19S particle have
been previously linked with transcription-
al activities (Ferdous et al., 2001), the
presence of proteasome core subunits is
unusual. This result raises several ques-
tions: Is the entire proteasome actually
present and therefore able to rapidly
destroy ubiquitinated proteins as they
are generated at the promoter? If this is
the case, how is the balance between
ubiquitin-mediated transcriptional activa-
tion and ubiquitin-mediated destruction
established? Presumably, licensing via
ubiquitination sets up a permissive state
for transcription that is rapidly eliminated
once transcription has initiated via
destruction of the transcriptional activa-
tor, but the mechanism that controls the
licensing window will need to be eluci-
dated if we are to understand the dynam-
ics of this process.
Until now, the major role for Skp2 in
promoting proliferation was ascribed to
its ability to induce p27 destruction, in
keeping with the finding that Skp2 cannot
induce S phase entry in cells expressing
nonphosphorylatable forms of p27
(Sutterluty et al., 1999). However, while
Skp2 can collaborate with Ras to trans-
form cells, Ras alone is unable to trans-
form cells lacking p27, suggesting the
existence of additional Skp2 targets
(Bashir and Pagano, 2003). Moreover,
Skp2 can promote S phase entry from
quiescence in mouse fibroblasts lacking
p27 (Y. Wei and J.W.H., unpublished
data). Therefore, the connection
between Skp2 and Myc suggests a new
view of the Skp2 pathway: Skp2 expres-
sion simultaneously leads to activation of
an oncogene (Myc) and destruction of a
Cdk inhibitor (p27) that normally serves
to impose a barrier against Cdk-driven S
phase entry. The unique proliferative
advantage these effects would have on
the cell provides a simple explanation for
why Skp2 is overexpressed in a wide
array of epithelial cancers (Bashir and
Pagano, 2003). What is not exactly clear
from this work is how Skp2−/− mice under-
go something approaching normal devel-
opment, yet presumably lack Myc
function, while mice lacking c-Myc dis-
play embryonic lethality. One would
expect that if Myc activity in vivo uniquely
required Skp2, then loss of Skp2 would
result in a more severe phenotype.
Clearly, further studies are needed to
determine whether only a subset of Myc-
responsive genes require Skp2 for Myc
responsiveness or whether alternative
pathways exist for Myc activation in par-
ticular cell lineages.
Although Kim et al. (2003) and von
der Lehr et al. (2003) demonstrated the
Skp2-dependent ubiquitination of Myc in
vivo, neither group was able to demon-
strate Myc ubiquitination by SCFSkp2 in
vitro, nor were they successful in demon-
strating a direct interaction between Myc
and Skp2. Cks1 is an essential accesso-
ry factor for p27 ubiquitination by SCFSkp2
(Bashir and Pagano, 2003). Might it be
the case that an accessory factor for Myc
is missing? Finding the ever elusive
accessory protein will be critical for eluci-
dating the mechanism by which Skp2 is
licensed to kill Myc.
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